Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Abreos Biosciences

Abreos Biosciences
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Seed LATEST DEAL TYPE
$1.2M LATEST DEAL AMOUNT
7 INVESTORS
Description

Developer of lateral flow assays that measure the activity of value biologics designed to offer a significant variation in how patients process biologic drugs. The company's lateral flow assays are laboratory-based and point-of-care assays that enable precision dosing and counterfeit detection of biologic drugs as well as allows for direct monitoring of blood concentrations of monoclonal antibody drugs for dosage, providing the health care industry with customizable assay.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 3550 General Atomics Court
  • Building G02, Room 559
  • San Diego, CA 92121
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Abreos Biosciences’s full profile, request a free trial.

Abreos Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Seed Round 07-Jun-2017 $1.2M 00.000 Completed Startup
6. Accelerator/Incubator 30-May-2017 00.000 Completed Clinical Trials - General
5. Early Stage VC (Series A) 29-Mar-2016 000 Cancelled Startup
4. Seed Round 28-Jun-2016 00.000 00.000 Completed Clinical Trials - General
3. Grant 25-Sep-2015 00000 Completed Startup
2. Grant 23-Sep-2014 $371K Completed Startup
1. Accelerator/Incubator 01-Jan-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Abreos Biosciences Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abgent Corporate Backed or Acquired San Diego, CA 00 000000&0
00000 00000000000 Formerly PE-Backed Littleton, CO 00 000000&0
00000000 000000000 Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
0000000 Angel-Backed Irvine, CA 00 00000 0000000000 00000
0000000 Accelerator/Incubator Backed San Francisco, CA 0 000000000000
To view this company’s complete list of competitors, request access »

Abreos Biosciences Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 (000000 0000000 27-Nov-2019 00000 0000000 Diagnostic Equipment 0000000 0000000 00.0
To view this company’s complete investment and acquisition history, request access »

Abreos Biosciences Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
TransMontaigne Partners Corporation Minority 000 0000 000000 0
MedTech Innovator Accelerator/Incubator 000 0000 000000 0
Blackbird Ventures (La Jolla) Venture Capital Minority 000 0000 000000 0
Keshif Ventures Angel Group 000 0000 000000 0
Vertical Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Abreos Biosciences Executive Team (8)

Name Title Board
Seat
Contact
Info
Bradley Messmer Ph.D Chief Executive Officer, Co-Founder & Board Member
Michael Little Ph.D Chief Operating Officer
William Yashar Director, Business Development
Neil Senturia Executive Chairman & Advisor

4 Former Executives

You’re viewing 4 of 8 executives. Get the full list »

Abreos Biosciences Board Members (3)

Name Representing Role Since Contact
Info
Bradley Messmer Ph.D Abreos Biosciences Chief Executive Officer, Co-Founder & Board Member 000 0000
Neil Senturia Self Executive Chairman & Advisor 000 0000

1 Former Board Member

You’re viewing 2 of 3 board members. Get the full list »